BioPharma Credit invests mainly in debt and equity within the life sciences sector by lending directly to life sciences companies or to entities that hold royalty rights for their products. The fund builds a diversified portfolio by acquiring different types of debt assets from a variety of borrowers and buying equities from these companies either directly or on the secondary market. This approach aims to generate consistent long-term income by leveraging various financial instruments related to the life sciences industry.